Caricamento...
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
BACKGROUND: The majority of current pharmacological treatments for Parkinson’s disease (PD) were approved for clinical use in the second half of the last century and they only provide symptomatic relief. Derivatives of these therapies continue to be explored in clinical trials, together with potenti...
Salvato in:
| Pubblicato in: | J Parkinsons Dis |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
IOS Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7458531/ https://ncbi.nlm.nih.gov/pubmed/32741777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-202128 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|